Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT07559162 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Ai Chi-Based Rehabilitation for Peripheral Unilateral Vestibular Dysfunction

Study acronym: AICHI-VR
StatusNot Yet Recruiting
PhaseNot applicable
Started
View on ClinicalTrials.gov ↗
Record status
This record was last updated May 7, 2026 (before its estimated May 27, 2026 completion). Its status may not reflect the trial's current state.

Record History

See every version on ClinicalTrials.gov ↗

  1. Minor Secondary endpoints revised (8)v2
  2. Minor Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
This study aims to evaluate the effects of an Ai Chi-based rehabilitation program on balance, dizziness severity, and quality of life in patients with unilateral peripheral vestibular hypofunction. Participants will be randomly assigned to either a control group receiving standard home-based vestibular rehabilitation exercises or an intervention group receiving additional Ai Chi sessions. The intervention will be conducted over a 4-week period with a total of 10 sessions under the supervision of a certified therapist.
Trial Details
NCT Number NCT07559162
Lead Sponsor Gaziosmanpasa Research and Education Hospital
Conditions
(from sponsor)
Unilateral Peripheral Vestibular Hypofunction, Vestibular Disorders, Dizziness, Vertigo Benign Positional, Dizziness and Vertigo, Vestibular Function Disorder
Related terms Benign Paroxysmal Positional Vertigo, Dizziness, Vertigo, Vestibular Diseases
Enrollment 38 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov